AJNR Am J Neuroradiol

1. PETROU K, Ploussi A, Seimenis I, Karavasilis E, et al
   Radiomics and Artificial Intelligence in Multiple Sclerosis MRI: A Comprehensive Review.
   AJNR Am J Neuroradiol. 2026 Feb 19:ajnr.A9245. doi: 10.3174/ajnr.A9245.
   

   >> Share

   
   

   
   BMC Neurol

2. TAN H, Zhou L, Gao Y, Zhao C, et al
   Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China.
   BMC Neurol. 2026 Feb 18. doi: 10.1186/s12883-026-04727.
   

   >> Share

   
   

   
   J Neurol

3. GUO J, Olsson T, Alfredsson L, Hedstrom AK, et al
   Disability progression in multiple sclerosis: a latent class analysis of predictors.
   J Neurol. 2026;273:157.
   

   >> Share

   
   

   
   Mult Scler

4. SIAVOSHI F, Noroozi R, Chang G, Schoeps VA, et al
   Accelerated metabolomic aging and its association with social determinants of health in multiple sclerosis.
   Mult Scler. 2026 Feb 20:13524585261417120. doi: 10.1177/13524585261417120.
   

   >> Share

   
   
5. MILLER A, Cohen JA, Karni A, Popper L, et al
   GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial.
   Mult Scler. 2026;32:202-213.
   

   >> Share

   
   
6. PATEL MA, Punnen TG, Shan KS, McCreary MC, et al
   Clinical and radiological outcomes of directed treatment transitions from Gilenya((R)) to generic fingolimod.
   Mult Scler. 2026;32:192-201.
   

   >> Share

   
   

   
   Neurol Clin Pract

7. HARTUNG DM, Gabriel N, Gellad WF, Cameron T, et al
   Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021.
   Neurol Clin Pract. 2026;16:e200597.
   

   >> Share

   
   

   
   Neurology

8. CHANDRA A, Acharya S, Chandra A
   Global & Community Health: Diagnosis and Management of Multiple Sclerosis in Nepal: Overcoming Barriers Through Local Adaptations.
   Neurology. 2026;106:e214743.
   

   >> Share

   
   

   
   PLoS One

9. DENG Q, Bai Q, Yang Y, Tang W, et al
   A new mechanism regulating microglial NLRP3 inflammasome: FMR1 mediates NLRP3 mRNA stability.
   PLoS One. 2026;21:e0341867.
   

   >> Share

   
   
10. AKBARI H, Ragerdi-Kashani I, Rezaei-Yazdi F, Pasbakhsh P, et al
    Effect of transplanted oligodendrocyte precursor cells derived from inflammatory and non-inflammatory microenvironment on remyelination in a chronic cuprizone model.
    PLoS One. 2026;21:e0343039.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

11. SARRAZIN N, Arab R, Cordano C, Brazhnikova E, et al
    Clemastine fumarate promotes myelin repair in a nonhuman primate model of demyelination characterized by absent spontaneous remyelination.
    Proc Natl Acad Sci U S A. 2026;123:e2520161123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share